:: OIP-ISR Home :: UCLA Home :: UCLA Invents ::  

http://www.research.ucla.edu/tech/biological_reagents.htm

  Mouse Models | Cell Lines | Antibodies | Biomarkers
Cell Biology Tools | Cell Media | Instruments | Additional Tools


Mouse Models
 Note:  ** Designates Mouse Models listed in this section available to license by using a prepared ready-to-sign agreement available online:  View and print agreement - pdf file.

  • 2009-718 Transgenic Mouse Model of Parkinson's Disease (PD) Exhibiting Age-dependent Disease Progression
  • 2009-522 Cre/LoxP Conditional Mouse Model of Huntington's Disease **
  • 2009-214 IFNAR Knockout Mouse
  • 2009-186 GPAT4 Knockout Mouse
  • 2008-020 Mouse Model for Conditional Knockout of the PTEN Gene
  • 2007-222 Mouse model for Premature Aging: Zmpste24 Knockout Mice **
  • 2006-625 Proton-sensing G Protein-couipled Receptor 4 Knockout **
  • 2006-624 Mouse Model Deficient for the Proton Sensing GPCR T cell Death-Associated Gene 8 (TDAG8) **
  • 2006-401 Inducible Dominant Negative DISC1 Transgenic Mice as a Model for Schizophrenia **
  • 2006-215 B-raf/loxP-flanked Mutant Mouse
  • 2005-492 Novel Mouse Model for Huntington's Disease
  • 2004-644 Adipose Tissue-Specific Pten Knockout Mice
  • 2004-600 Transgenic Mouse with Prostate Specific Expression of a Reporter Gene
  • 2004-073 Murine PTEN Null Prostate Cancer Model
  • 2003-053 Genetically Engineered Mouse Lacking Tumor Suppressor Gene in the Brain
  • 2002-274 TCL1 Transgenic Mice **
  • 2002-135 C-MYC Transgenic Mouse
  • 2002-133 Use of a Gene and Related Mouse Model for the Study and Development of Therapeutics for Neuropsychiatric Disorders
  • 2001-466 Pituitary Adenylyl Cyclase-Activating Peptide (PACAP) Deficient Mice **
  • 2001-173 Vasoactive Intestinal Peptide (VIP) and Peptide Histidine Isoleucine (PHI) Knockout Mice **
  • 1998-608 Myeloperoxidase-Deficient Mouse **


    • Cell Lines
  • 2009-299 Supporting Cell Lines that Improve Gamete Production from Human Pluripotent Cells
  • 2005-059 Pten Null Cell Lines
  • 2004-351 Reagents to Induce and Quantitate Notch Signal Transduction in Mammalian Cells
  • 1999-548 A Human Inflammatory Breast Carcinoma Xenograft Model of the Intravasation Step of Metastasis
  • 1991-531 Cell Lines for the Study of Kaposi's Sarcoma and Smooth Muscle Cells
  • 1999-549 A Feline Bronchioloalveolar Lung Carcinoma (BAC) Xenograft and Cell Line for the Study of Common Animal and Human Pathogens


    • Antibodies (View complete listing excel file)
  • 2009-306 Polyclonal Antibody Against Histone H3 Lysine 18 Acetylation
  • 2009-010 Monoclonal Antibody Recognizing Human ABL2
  • 2008-735 Antibodies Against Mouse Nuclear Proteins
  • 2008-679 Monoclonal Antibody to CDK2AP-1
  • 2007-216 Vectors for Antibody Expression
  • 2006-594 Anti-MAGI-2 Rabbit Polyclonal Antibody
  • 2003-450 Phospho-Specific Antibody for CaM Kinase II
  • 1998-610 Hybrid IgA/IgG Polymeric Antibodies
  • 1997-592 Novel Polyclonal Antibody to Detect a Burton's Tryosine Kinase (Btk) Phosphorylation Site
  • 1997-545 Production of Secretory IgA with Increased Stability


    • Biomarkers
  • 2009-752 DNA-based Biomarkers for Human Stem Cells and Derivatives
  • 2009-047 Peptide Epitopes as Biomarkers for Prostate Cancer
  • 2008-799 Genomic Predictor of Kidney Cancer Prognosis and IL-2 Treatment Response
  • 2007-713 Periperal Biomarkers for the Assessment of Autism
  • 2006-726 Aromatase Expression Predicts Survival in Women with Early Stage Non-small Cell Lung Cancer
  • 2006-242 Biomarkers for Oral Tongue Cancer Metastasis and Extracapsular Spread (ECS)
  • 2005-452 Molecular Determinants of EGFR Kinase Inhibitor Response in Glioblastoma
  • 2005-017 Novel Prognostic Factor and Therapeutic Target in Human Renal Cell Carcinoma
  • 2004-496 Simplified Method for Producing a Panel Array of Biomarkers for Detection, Prognosis and Prediction of Multiple Cancers
  • 2004-194 YY1: Novel Prognostic Factor in Human Prostate Cancer
  • 2004-191 Genetic Risk Marker for Alzheimer's Disease (AD) and Frontotemporal Dementia (FTD)
  • 1999-402 Diagnostic and Therapeutic Methods using the H37 Tumor Suppressor Gene
  • 1994-507 A Sensitive Biomarker of Low-Level Lead Exposure

    • Cell Biology Tools
  • 2007-564 Minimally Invasive Single-cell Surgery Tool Based on Photothermal Effects of Metal Nanoparticles
  • 2007-477 Cell Separation Device using High Electromagnetic Gradients Through a Particle-based Microfluidic Approach
  • 2007-095 Self-contained Cell Culture Device for Cell Separation and Sorting
  • 2005-246 Intelligent Response-Dependent Stimulation of Cells for Basic Research and Drug Discovery Applications
  • 2004-275 A MXXXL Motif Confering Endocytosis of Biomolecules
  • 2002-491

    Cloned Zebrafish from Long-term Cultured Cells
  • 1997-539 Genomic Screening with a Chemical Nuclease
  • 1997-543 Reaction of Purines with Elemental Fluorine to Generate 8-Fluoropurines
  • 1993-561 Simpler, Faster System for Routine DNA Sequencing


    • Cell Media
    Chemically Defined Human Embryonic Stem Cell Media
  • 2004-098 Bacterial Growth Media Derived from Non-mammalian Components
  • 2003-190 Medium Formula for Inducing Neural Stem Cells into Oligodendrocytes (OL)
  • 2002-475 Serum-Free Culture Medium for Maintaining and Propagating Neural Stem Cells (NSCs)
  • 2002-004 Vector for Tissue Specific Amplification of Both Reporter and Therapeutic Genes


    • Instruments
  • 2007-570 Integrated Microfluid Platform for Parallel Screening of a Chemical Library
  • 2006-526 Stimulated Raman Spectroscopy and Microscopy with an All-electronic Spectrometer
  • 2005-659 Nanoscale Blood Sampling System
  • 2002-500 Single Cell Nano-mechanical Stethoscope


    • Additional Tools
  • 2009-581 Chemically Defined Human Embryonic Stem Cell Media
  • 2009-084 Small Molecule Inhibitors Improve the Survival and Growth of Human Embryonic Stem Cells
  • 2005-379 Improvement of Dental Resins: Decreased toxicity and improved biocompatibility
  • 2005-023 A Novel System for Measuring Protease Activity
  • 2004-099 Artificial Human Mutation Controls for Clinical Diagnostic Genetic and Proficiency Testing
  • 2003-195 Clinical Tool for Determining Anti-Aggregation Activity of Alzheimer's Therapeutics
  • 2003-075 Shape Encoded Particles (SEPS) for Use in Solution Arrays and Decoding Software
  • 2002-222 Coated Filter for Growing Reusable Organotypic Tissue Slices
  • 2000-128 Targeting Lentiviral Vectors to Specific Cells and Tissues
  • 1998-601 Enantioseparation of Amino Acids Using a Chiral Recognition Polymer
  • 1995-560 A Method for Preparing Organically Functionalized Monodisperse Nanoparticles of Catalytically Active and Non-Catalytically Active Noble Metals
  • 1995-543 RNA Binding Fluorochrome: Fluoro Nissl Green
  • 1994-534 Selective Localization of Ultrasound Contrast Agent

    		•
    		 
    UCLA
    Technology
    Commercialization
    Opportunities


    Select sub-categories in:
    All Life Sci Tech
    All Phy Sci Tech

    The Office of Intellectual Property (OIP) manages a campus-wide patent and invention portfolio resulting from UCLA research funded by more than $950 million per year in federal, state and private contracts and grants.

     Office Address:

     Office of Intellectual Property
    11000 Kinross Ave., Suite 200
    Los Angeles, CA 90095-7231
    Tel. 310.794.0558

    http://www.oip.ucla.edu/






    :: UCLA Lab Directory


    :: UCLA Research Interests
    :: UCLA Invents


    :: Campus Directory
    :: UCLA main research page
    :: UCLA Home Page
    :: About UCLA


    Copyright © 2009 The Regents of the University of California